Loading company…
Daejeon-based pharmaceutical company developing drugs for central nervous system diseases.
Based in Daejeon, South Korea and founded in 2018, SoVarGen Co., Ltd. researches and develops drugs for central nervous system (CNS) diseases. In June 2026 it raised approximately KRW 11.9 billion in pre-IPO funding led by returning investor Atinum Investment, with participation from Hyundai Investment Partners. New investors DSC Investment, Premier Partners and A-Stone Ventures also joined the round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in